Egypt Opens First Phase of Vaccine and Biotechnology City

Egyptian health authorities inaugurated the first phase of the Vaccine and Biotechnology City on Monday, marking a step toward expanding the country’s pharmaceutical production capacity.

The project aims to strengthen Egypt’s ability to manufacture both human and veterinary vaccines, with local production central to its objectives.

Reducing reliance on imported vaccines is another key goal. The initiative seeks to build domestic capabilities to support that shift.

The city is also intended to establish a production and technological base that will enable Egypt to expand vaccine manufacturing over time.

Beyond serving domestic needs, the project aims to lay the groundwork for exports to foreign markets as Egypt develops its vaccine and biotechnology industry.